Ardelyx reported $-0.15 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
0.04 Oct/29
-0.07 -0.03 -0.08 Aug/06
FY2025Q1 Mar/2026 -0.15 -0.12 -0.17 Apr/30




Eps Change Date
Abbott USD 1.31 0.16 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
Ardelyx USD -0.15 0.15 Mar/2026
aTyr Pharma USD -0.06 0.59 Mar/2026
Corcept Therapeutics USD 0.36 0.66 Jun/2026
Curis USD -11.82 13.04 Mar/2026
Sanofi EUR 2.17 2.84 Mar/2026
TG Therapeutics USD 0.05 0.07 Jun/2026
United Therapeutics USD 7.27 1.45 Jun/2026